156 related articles for article (PubMed ID: 2107283)
1. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF
J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283
[TBL] [Abstract][Full Text] [Related]
2. Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.
Adams GP; DeNardo SJ; Deshpande SV; DeNardo GL; Meares CF; McCall MJ; Epstein AL
Cancer Res; 1989 Apr; 49(7):1707-11. PubMed ID: 2493983
[TBL] [Abstract][Full Text] [Related]
3. Comparative serum stability of radiochelates for antibody radiopharmaceuticals.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
J Nucl Med; 1987 Jan; 28(1):83-90. PubMed ID: 3794813
[TBL] [Abstract][Full Text] [Related]
4. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
Kinuya S; Jeong JM; Garmestani K; Saga T; Camera L; Brechbiel MW; Gansow OA; Carrasquillo JA; Neumann RD; Paik CH
J Nucl Med; 1994 Nov; 35(11):1851-7. PubMed ID: 7965168
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
6. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
[TBL] [Abstract][Full Text] [Related]
7. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.
Jones PL; Brown BA; Sands H
Cancer Res; 1990 Feb; 50(3 Suppl):852s-856s. PubMed ID: 2297733
[TBL] [Abstract][Full Text] [Related]
8. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
Sun B
Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
[TBL] [Abstract][Full Text] [Related]
11. Metal decomposition rates of 111In-DTPA and EDTA conjugates of monoclonal antibodies in vivo.
Goodwin DA; Meares CF; McTigue M; McCall MJ; Chaovapong W
Nucl Med Commun; 1986 Nov; 7(11):831-8. PubMed ID: 3106867
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
13. Uptake of indium-111 in the liver of mice following administration of indium-111-DTPA-labeled monoclonal antibodies: influence of labeling parameters, physiologic parameters, and antibody dose.
Schuhmacher J; Klivényi G; Matys R; Kirchgebner H; Hauser H; Maier-Borst W; Matzku S
J Nucl Med; 1990 Jun; 31(6):1084-93. PubMed ID: 2348237
[TBL] [Abstract][Full Text] [Related]
14. 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.
Tolmachev V; Nilsson FY; Widström C; Andersson K; Rosik D; Gedda L; Wennborg A; Orlova A
J Nucl Med; 2006 May; 47(5):846-53. PubMed ID: 16644755
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability of EDTA and DTPA immunoconjugates of monoclonal antibody 2G3 labeled with indium-111.
Reilly R; Lee N; Houle S; Law J; Marks A
Int J Rad Appl Instrum A; 1992 Aug; 43(8):961-7. PubMed ID: 1330982
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study.
Kramer EL; DeNardo SJ; Liebes L; Kroger LA; Noz ME; Mizrachi H; Salako QA; Furmanski P; Glenn SD; DeNardo GL
J Nucl Med; 1993 Jul; 34(7):1067-74. PubMed ID: 8315480
[TBL] [Abstract][Full Text] [Related]
18. A new radiochemical method to determine the stability constants of metal chelates attached to a protein.
Subramanian KM; Wolf W
J Nucl Med; 1990 Apr; 31(4):480-8. PubMed ID: 2109050
[TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
DeNardo GL; O'Donnell RT; Shen S; Kroger LA; Yuan A; Meares CF; Kukis DL; DeNardo SJ
J Nucl Med; 2000 May; 41(5):952-8. PubMed ID: 10809213
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
Sun B
Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]